Prevalence, type of epilepsy and use of antiepileptic drugs in primary care;Prevalencia, tipo de epilepsia y uso de fármacos antiepilépticos en atención primaria

Revista de Neurologia

Volumn 60, Issue 12, 2015, Pages 535-542

  Fernández Suárez, Elena ^a   Villa Estébanez, Rubén ^a   García Martínez, Alberto ^b   Fidalgo González, José A ^c   Zanabili Al Sibbai, Ahmad A ^d   Salas Puig, Javier ^e  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b Servicio de Neurología   (Spain)

^c Servicio de Medicina Fisica y Rehabilitación   (Spain)

^d Serv Angiologia y Cirugia Vasc II   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Adverse effects; Antiepileptic drugs; Epilepsy; Precipitating factors; Prevalence; Seizure type

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; LAMOTRIGINE; PHENYTOIN; VALPROIC ACID;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DESCRIPTIVE RESEARCH; DRUG USE; EPILEPSY; FEMALE; FOLLOW UP; GENERALIZED EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MONOTHERAPY; PREVALENCE; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; SEIZURE; ADOLESCENT; AGED; CHILD; CLASSIFICATION; INFANT; MIDDLE AGED; PRESCHOOL CHILD; PRIMARY HEALTH CARE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EPILEPSY; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PREVALENCE; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84932613313     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.6012.2015038     Document Type: Article

References (25)

1. Fisher RS, Van Emde Boas W, Blume W, Elger C, Genton P, Lee P, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005; 46: 470-2
2. Mc Hugh JC, Delanty N. Epidemiology and classification of epilepsy: gender comparisons. Int Rev Neurobiol 2008; 83: 11-26
3. Thurman DJ, Beghi E, Begley CE, Berg AT, Buchhalter JR, Hesdorffer DC, et al. ILAE Epidemiology Commission Report: standards for epidemiologic studies and surveillance of epilepsy. Epilepsia 2011; 52: 2-26
4. Hauser WA, Annegers JF, Rocca WA. Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Clin Proc 1996; 71: 576-86
5. Pradilla A, Vesga B, León-Sarmiento F. Estudio neuro-epidemiológico nacional (EPINEURO) colombiano. Rev Panam Salud Pública 2003; 14: 104-11
6. Olafsson E, Hauser WA. Prevalence of epilepsy in rural Iceland: a population-based study. Epilepsia 1999; 40: 1529-34
7. Luengo A, Parra J, Colas J, Ramos F, Carreras T, Fernández-Pozos MJ, et al. Prevalence of epilepsy in northeast Madrid. J Neurol 2001; 248: 762-7
8. Benavente I, Rubio E, Morales C, Tajada N, Tamargo P. Prevalence of epilepsy amongst adolescents in Huesca, Spain: a community-based study. Eur J Neurol 2009; 16: 1138-43
9. García-Martín G, Pérez-Errazquin F, Chamorro-Muñoz MI, Romer-Acebal M, Martin-Reyes G, Dawid-Milner MS. Prevalence and clinical characteristics in the South of Spain. Epilepsy Res 2012; 102: 100-8
10. Rufo-Campos M. Pautas terapéuticas en el paciente con epilepsia farmacorresistente en consultas ambulatorias de neurología y epilepsia en España. Rev Neurol 2008; 47: 517-24
11. Quiñones-Núñez M, Lira-Mamani D. Perfil epidemiológico de la epilepsia en una población hospitalaria en Lima, Perú. Rev Neurol 2004; 38: 712-5
12. Carod-Artal FJ, Vargas AP, Mesquita HM. Etiología de las crisis epilépticas en un centro de rehabilitación. Rev Neurol 2009; 49: 349-53
13. Banerjee PN, Filippi D, Allen Hauser W. The descriptive epidemiology of epilepsy -a review. Epilepsy Res 2009; 85: 31-45
14. Forsgren L. Prevalence of epilepsy in adults in Northern Sweden. Epilepsia 1992; 33: 450
15. Leppik IE, Birnbaum AK. Epilepsy in the elderly. Ann N Y Acad Sci 2010; 1184: 208-24
16. Oller LF-V. Prevalencia de los distintos tipos de epilepsia en la práctica clínica. Rev Neurol 2002; 34: 526-31
17. Arteaga-Rodríguez C, Ramírez-Chávez J, Rodríguez-Rivera L, Morera-Méndez F, Hernández-Fustes OJ. Factores etiológicos de las epilepsias. Rev Neurol 1998; 27: 427-30
18. Cruz-Campos GA, Baquero-Toledo M. Epilepsias en el ámbito extrahospitalario. Estudio en 150 casos. Rev Neurol 2000; 30: 1108-12
19. Torres-Ferrús M, Toledo M, González-Cuevas M, Seró-Ballesteros L, Santamarina E, Raspall-Chaure M, et al. Etiología y tratamiento de la epilepsia en una serie de 1.557 pacientes. Rev Neurol 2013; 57: 306-12
20. Frucht MM, Quigg M, Schwaner C, Fountain NB. Distribution of seizure precipitants among epilepsy syndromes. Epilepsia 2000; 41: 1534-9
21. Nakken KO, Solaas MH, Kjeldsen MJ, Friis ML, Pellock JM, Corey LA. Which seizure-precipitating factors do patients with epilepsy most frequently report? Epilepsy Behav 2005; 6: 85-9
22. Kanner AM, Balabanov AJ. The use of monotherapy in patients with epilepsy: an appraisal of the new antiepileptic drugs. Curr Neurol Neurosci Rep 2005; 5: 322-8
23. Paschal AM, Hawley SR, St Romain T, Ablah E. Measures of adherence to epilepsy treatment: review of present practices and recommendations for future directions. Epilepsia 2008; 49: 1115-22
24. Kwan P, Brodie MJ. Combination therapy in epilepsy: when and what to use. Drugs 2006; 66: 1817-29
25. Villanueva V, Sánchez-Alvarez JC, Peña P, Salas-Puig J, Caballero-Martínez F, Gil-Nagel A. Treatment initiation in epilepsy: an expert consensus in Spain. Epilepsy Behav 2010; 19: 332-42